BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Who is Adm. Frank 'Mitch' Bradley and what does he have to do with the Venezuela boat strikes? - 2The most effective method to Pick A Trade-in vehicle Stage
- 3Wait, it's 'Harry Potter and the Philosopher's Stone'? Why the new HBO series name is significant to Americans
- 4Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- 5Australians told to continue Easter travel plans despite fuel shortages
- At least 30 killed in attack on Nigeria village
- The most effective method to Explore Moral Situations in Brain research with Your Certification
- 'An incredible privilege and responsibility': Artemis 2's Christina Koch is ready to become the 1st woman to fly around the moon
- Vote in favor of Your #1 4\u00d74 SUVs
- 7 Strange Apparatuses to Make Your Party Stick Out!
- US FDA approves Kura-Kyowa's blood cancer therapy
- The most effective method to Recognize a Great Lab Jewel
- Current Chateaus: Advancement and Style
- Kate Hudson, 46, says she doesn't need long workouts to feel good
